← Back to Search

Corticosteroid

ACTHAR Gel 40 units twice weekly for Sarcoidosis

Phase 2 & 3
Waitlist Available
Led By Marc A Judson, MD
Research Sponsored by Albany Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between week 0 and week 12.
Awards & highlights

Summary

ACTHAR gel has efficacy in the treatment of cutaneous sarcoidosis

Eligible Conditions
  • Sarcoidosis
  • Cutaneous Sarcoidosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between week 0 and week 12.
This trial's timeline: 3 weeks for screening, Varies for treatment, and between week 0 and week 12. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Extent of granulomatous inflammation in the biopsy lesion
Photographic change

Trial Design

2Treatment groups
Experimental Treatment
Group I: ACTHAR Gel 80 units twice weeklyExperimental Treatment1 Intervention
ACTHAR gel at a dose of 80 units twice weekly sub cutaneous injections between Baseline and week 12.
Group II: ACTHAR Gel 40 units twice weeklyExperimental Treatment1 Intervention
ACTHAR Gel at a dose of 40 units twice weekly sub cutaneous injections between Baseline and week 12.

Find a Location

Who is running the clinical trial?

Albany Medical CollegeLead Sponsor
92 Previous Clinical Trials
12,789 Total Patients Enrolled
3 Trials studying Sarcoidosis
410 Patients Enrolled for Sarcoidosis
Marc A Judson, MDPrincipal InvestigatorAlbany Medical College
3 Previous Clinical Trials
46 Total Patients Enrolled
3 Trials studying Sarcoidosis
46 Patients Enrolled for Sarcoidosis
~1 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top